MedPath

Huaier Granule for Treatment of Plasma Cell Mastitis: a multicenter real world study

Phase 4
Recruiting
Conditions
Plasma Cell Mastitis
Registration Number
ITMCTR2100004385
Lead Sponsor
Qilu Hospital of Shandong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Histopathologically confirmed PCM or clinical imaging diagnosed with PCM;
2. Patients over 18 years old;
3. Before the start of the study, patient fully understands the study and is willing to sign the informed consent form.

Exclusion Criteria

1. Pregnant or lactating women, or plan a pregnancy during the study period;
2. With severe heart, liver, kidney, endocrine system disease patients;
3. Allergic to Huaier Granule or its composition;
4. Poor compliance or have conditions that are considered not suitable for this study investigators.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EORTC QLQ-C30;
Secondary Outcome Measures
NameTimeMethod
Karnofsky;
© Copyright 2025. All Rights Reserved by MedPath